168 related articles for article (PubMed ID: 21791942)
61. Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
Brandes AA; Tosoni A; Basso U; Reni M; Valduga F; Monfardini S; Amistà P; Nicolardi L; Sotti G; Ermani M
J Clin Oncol; 2004 Dec; 22(23):4779-86. PubMed ID: 15570079
[TBL] [Abstract][Full Text] [Related]
62. Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study.
Perry JR; Bélanger K; Mason WP; Fulton D; Kavan P; Easaw J; Shields C; Kirby S; Macdonald DR; Eisenstat DD; Thiessen B; Forsyth P; Pouliot JF
J Clin Oncol; 2010 Apr; 28(12):2051-7. PubMed ID: 20308655
[TBL] [Abstract][Full Text] [Related]
63. Successful treatment of primary intracranial sarcoma with the ICE chemotherapy regimen and focal radiation in children.
Lafay-Cousin L; Lindzon G; Taylor MD; Hader W; Hawkins C; Nordal R; Laperriere N; Laughlin S; Bouffet E; Bartels U
J Neurosurg Pediatr; 2016 Mar; 17(3):298-302. PubMed ID: 26588458
[TBL] [Abstract][Full Text] [Related]
64. Ifosfamide/carboplatin/etoposide chemotherapy for metastatic breast cancer with or without autologous hematopoietic stem cell transplantation: evaluation of dose-response relationships.
Perkins JB; Fields KK; Elfenbein GJ
Semin Oncol; 1995 Jun; 22(3 Suppl 7):5-8. PubMed ID: 7610398
[TBL] [Abstract][Full Text] [Related]
65. Chemotherapy in the treatment of recurrent glioblastoma multiforme: ifosfamide versus temozolomide.
Paulsen F; Hoffmann W; Becker G; Belka C; Weinmann M; Classen J; Kortmann RD; Bamberg M
J Cancer Res Clin Oncol; 1999 Jul; 125(7):411-8. PubMed ID: 10394962
[TBL] [Abstract][Full Text] [Related]
66. Cisplatin and etoposide combination therapy for primary glial tumors: preliminary results.
Boiardi A; Silvani A; Milanesi I; Munari L; Solero CL; Botturi M
Ital J Neurol Sci; 1991 Feb; 12(1):33-7. PubMed ID: 1849504
[TBL] [Abstract][Full Text] [Related]
67. An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting.
Kyritsis AP; Levin VA
Cancer Chemother Pharmacol; 2011 May; 67(5):971-83. PubMed ID: 21442438
[TBL] [Abstract][Full Text] [Related]
68. Preliminary data by cis-platin and etoposide using in primary glioblastoma.
Milanesi I; Silvani A; Munari L; Solero CL; Botturi M; Boiardi A
J Neurosurg Sci; 1990; 34(3-4):279-82. PubMed ID: 1965906
[TBL] [Abstract][Full Text] [Related]
69. Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials.
Wong ET; Hess KR; Gleason MJ; Jaeckle KA; Kyritsis AP; Prados MD; Levin VA; Yung WK
J Clin Oncol; 1999 Aug; 17(8):2572-8. PubMed ID: 10561324
[TBL] [Abstract][Full Text] [Related]
70. Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumors.
Scopece L; Franceschi E; Cavallo G; Paioli A; Paioli G; Conforti R; Palmerini E; Berzioli C; Spagnolli F; Esposti RD; Crinò L
J Neurooncol; 2006 Sep; 79(3):299-305. PubMed ID: 16645720
[TBL] [Abstract][Full Text] [Related]
71. Intra-arterial cisplatin plus oral etoposide for the treatment of recurrent malignant glioma: a phase II study.
Ashby LS; Shapiro WR
J Neurooncol; 2001 Jan; 51(1):67-86. PubMed ID: 11349883
[TBL] [Abstract][Full Text] [Related]
72. Ifosfamide/carboplatin/etoposide (ICE), an effective salvaging therapy for recurrent malignant non-Hodgkin lymphoma of childhood: a Pediatric Oncology Group phase II study.
Kung FH; Harris MB; Krischer JP
Med Pediatr Oncol; 1999 Mar; 32(3):225-6. PubMed ID: 10064193
[No Abstract] [Full Text] [Related]
73. Combined carboplatin and etoposide chemotherapy for patients with recurrent glioma.
Chen J; Zhao Y; Hou X; Gao X; Shi Q; Li S; Huang H
Ann Palliat Med; 2021 Dec; 10(12):12650-12656. PubMed ID: 35016422
[TBL] [Abstract][Full Text] [Related]
74. Interobserver variability in the radiological assessment of response to chemotherapy in glioma.
Vos MJ; Uitdehaag BM; Barkhof F; Heimans JJ; Baayen HC; Boogerd W; Castelijns JA; Elkhuizen PH; Postma TJ
Neurology; 2003 Mar; 60(5):826-30. PubMed ID: 12629241
[TBL] [Abstract][Full Text] [Related]
75. Imaging response to chemotherapy with RMP-7 and carboplatin in malignant glioma: size matters but speed does not.
Grant R; Walker M; Hadley D; Barton T; Osborn C
J Neurooncol; 2002 May; 57(3):241-5. PubMed ID: 12125987
[TBL] [Abstract][Full Text] [Related]
76. Carboplatin and etoposide for recurrent malignant glioma following surgical and radiotherapy failure: A clinical study conducted at the Northern Israel Oncology Center.
Stein ME; Kuten A; Drumea K; Goldsher D; Tzuk-Shina Z
J Surg Oncol; 1999 Jul; 71(3):167-70. PubMed ID: 10404133
[TBL] [Abstract][Full Text] [Related]
77. A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma - A final report.
Gnekow AK; Walker DA; Kandels D; Picton S; Giorgio Perilongo ; Grill J; Stokland T; Sandstrom PE; Warmuth-Metz M; Pietsch T; Giangaspero F; Schmidt R; Faldum A; Kilmartin D; De Paoli A; De Salvo GL;
Eur J Cancer; 2017 Aug; 81():206-225. PubMed ID: 28649001
[TBL] [Abstract][Full Text] [Related]
78. Carboplatin combined with carmustine and etoposide in the treatment of glioblastoma.
Boiardi A; Silvani A; Milanesi I; Botturi M; Broggi G
Ital J Neurol Sci; 1992 Dec; 13(9):717-22. PubMed ID: 1483854
[TBL] [Abstract][Full Text] [Related]
79. Treatment of paediatric pontine glioma with oral trophosphamide and etoposide.
Wolff JE; Westphal S; Mölenkamp G; Gnekow A; Warmuth-Metz M; Rating D; Kuehl J
Br J Cancer; 2002 Oct; 87(9):945-9. PubMed ID: 12434281
[TBL] [Abstract][Full Text] [Related]
80. Salvage chemotherapy in progressive high-grade astrocytoma.
See SJ; Ty A; Wong MC
Ann Acad Med Singap; 2007 May; 36(5):343-6. PubMed ID: 17549281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
